Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Net Cash Flow (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Net Cash Flow for 3 consecutive years, with $34.8 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow fell 43.37% to $34.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $46.1 million through Dec 2025, up 79.64% year-over-year, with the annual reading at $46.1 million for FY2025, 79.64% up from the prior year.
  • Net Cash Flow hit $34.8 million in Q4 2025 for Camp4 Therapeutics, down from $36.2 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $61.5 million in Q4 2024 to a low of -$14.7 million in Q1 2025.
  • Historically, Net Cash Flow has averaged $6.6 million across 3 years, with a median of -$10.2 million in 2025.
  • Biggest five-year swings in Net Cash Flow: soared 608.82% in 2024 and later tumbled 43.37% in 2025.
  • Year by year, Net Cash Flow stood at -$12.1 million in 2023, then skyrocketed by 608.82% to $61.5 million in 2024, then crashed by 43.37% to $34.8 million in 2025.
  • Business Quant data shows Net Cash Flow for CAMP at $34.8 million in Q4 2025, $36.2 million in Q3 2025, and -$10.2 million in Q2 2025.